Skip to main content

Table 3 Overview of all adverse events reported during the trial (1 year follow up)

From: A randomised controlled trial to examine the effects of cinacalcet on bone and cardiovascular parameters in haemodialysis patients with advanced secondary hyperparathyroidism

Description

Cinacalcet No of patients (no of events)

Control No of patients (no of events)

Details of events

p-Value

Infection

2 (3)

6 (7)

 

0.43

Renal transplant

1

2 (2)

 

0.7

Vascular access procedures

4 (11)

1

 

0.06

Death

 

1

brain tumour

0.4

Parathyroidectomy

 

1

 

0.4

Low calcium

11 (20)

4 (5)

< 2.1 mmol/L

0.01

High calcium

2 (5)

9 (17)

> 2.6 mmol/L

0.06

Claustrophobia

3

1

In MR scan

0.4

Other

11 (16)

12 (20)

 

0.4